From Scientific Research to Healthcare Markets: Empirical Essays on the Economics of Pharmaceutical Innovation

Improving health is a fundamental goal of modern societies. New pharmaceutical treatments have contributed significantly to progress in public health and life expectancy (Lichtenberg 2019). However, the development of new drugs is a costly endeavor. Therefore, how to effectively and efficiently promote biomedical science and pharmaceutical innovation is a first-order economic and policy concern. This dissertation sheds light on three stimuli for biomedical science and pharmaceutical innovation.

Publications

• Byrski, Dennis; Wang, Lucy X. (2023). Marketing Authorization and Strategic Patenting: Evidence from Pharmaceuticals, SSRN Working Paper, No. 4638115, DOI.
• Byrski, Dennis (2021). From Scientific Research to Healthcare Markets: Empirical Essays on the Economics of Pharmaceutical Innovation, Dissertation, LMU München: Faculty of Economics, DOI.
• Byrski, Dennis; Gaessler, Fabian; Higgins, Matthew J. (2021). Market Size and Research: Evidence from the Pharmaceutical Industry, Max Planck Institute for Innovation & Competition Research Paper, No. 21-16, DOI, and NBER Working Paper, No. w28858, DOI.
• Baruffaldi, Stefano H.; Byrski, Dennis; Gaessler, Fabian (2020). Fire and Mice: The Effect of Supply Shocks on Basic Science, Academy of Management Proceedings, 2020 (1), 14405, DOI.